Balversa
Balversa Approved for Locally Advanced or Metastatic Urothelial Carcinoma
The FDA approved erdafitinib (Balversa, Janssen Biotech) for adult patients with locally advanced or metastatic ...
JANUARY 22, 2024

Load more